Mounjaro is used to treat type 2 diabetes alone or in combination with other medications. Mounjaro is injected under the skin once weekly and may be increased based on clinical response and tolerance. Follow package instructions upon receiving the product.
- A once weekly injection used for the treatment of Type 2 diabetes alone or in combination with other medications to help lower hemoglobin A1c
- Used in combination with diet and exercise intervention
- Dosing begins at 2.5 mg once weekly for 4 weeks then increased to 5 mg weekly
- Lower doses can help minimize stomach upset and titration can be delayed based on tolerance
- Injected in the upper arm, thigh, or abdomen without regard to meals
-
Side Effects
Side effects include injection site reactions, constipation, diarrhea, and stomach pain.
-
Consumer Information Use and Disclaimer
This information should not be used to decide whether or not to take this medicine or any other medicine. Only a healthcare provider has the knowledge and training to decide which medicines are right for you. TelyRx does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a limited summary of general information about the medicine’s uses from the patient education materials and is not intended to be comprehensive. This limited summary does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this medicine. This information is not intended to provide medical advice, diagnosis or treatment and does not replace information you may receive from your healthcare provider. For a more detailed summary of information about the risks and benefits of using this medicine, please review the entire patient education information you receive with the medication.